On the pediatrics shelf, neonatal jaundice arrives as a yellow newborn with a timestamp: hours of life, gestational age, the mother's blood type, feeding and sometimes stool color. The question tests three decisions: is the jaundice too early, is the bilirubin above the hour-specific threshold, and is it conjugated. The 2022 AAP guideline raised the phototherapy thresholds, so older cutoffs may now be wrong.
The algorithm
Steps 1 to 8 cover week one; step 9 catches cholestasis.
- Check the hour of onsetJaundice in the first 24 hours most likely means hemolysis: measure a TSB or TcB as soon as possible (NICE: within 2 hours). Onset on days 2 to 5 in a well, feeding infant fits the physiologic rise.
- Get a number, not a skin estimateEvery infant at 35 weeks or more gets a TcB or TSB at 24 to 48 hours, or before discharge if earlier. The eye is unreliable, more so in darker skin. Confirm with a TSB any TcB of 15 mg/dL or more, or within 3 mg/dL of the threshold; treatment decisions use the TSB.
- Plot it on the right curveAAP 2022 thresholds rise with gestational age and hours of age, and are lower with any neurotoxicity risk factor: gestational age under 38 weeks, albumin under 3.0 g/dL, isoimmune hemolysis, G6PD deficiency or other hemolysis, sepsis, or significant clinical instability in the past 24 hours. At 40 weeks or more with no risk factors the threshold is 13.3 mg/dL at 24 hours and 21.8 mg/dL at 96 hours.
- Look for hemolysisSend infant blood type and DAT if the mother's antibody screen is positive or unknown, or if an infant needing phototherapy has a group O or Rh(D)-negative mother. A rise of 0.3 mg/dL per hour or more on day 1, or 0.2 mg/dL per hour or more after, suggests hemolysis. Check G6PD activity when unexplained jaundice rises despite intensive phototherapy, rises suddenly or after falling, or needs escalation.
- At or above the phototherapy threshold: treat and keep feedingStart phototherapy and recheck the TSB within 12 hours. Keep feeding; do not give water or dextrose water. With poor intake (over 10% weight loss, few wet or dirty diapers), add lactation support and consider expressed milk, donor milk or formula. Sunlight is not a treatment.
- Within 2 mg/dL of the exchange threshold: escalateSend STAT total and direct bilirubin, CBC, albumin, chemistries and type and crossmatch; give IV fluids and intensive phototherapy; move to a NICU that can do an exchange; repeat the TSB at least every 2 hours. With a positive DAT, IVIG 0.5 to 1 g/kg over 2 hours is an option.
- Exchange transfusionUrgent when the TSB reaches the exchange threshold or for signs of intermediate or advanced acute bilirubin encephalopathy: hypertonia, arching, retrocollis, opisthotonos, high-pitched cry, recurrent apnea. Early signs are quieter: sleepiness, poor suck, hypotonia.
- Stop phototherapy, then check for reboundStopping is an option once the TSB is at least 2 mg/dL below the threshold at which it started. Started before 48 hours, positive DAT or hemolysis: recheck 6 to 12 hours after stopping and again the next day; otherwise the next day.
- Still yellow at 2 to 4 weeks: fractionateCheck total and direct bilirubin if formula-fed and jaundiced at 2 weeks, or breastfed and jaundiced at 3 to 4 weeks. Direct bilirubin above 1.0 mg/dL is abnormal: check stool color (pale stool is a biliary atresia red flag), get a fasting ultrasound, urine culture and thyroid tests, and refer to pediatric GI or hepatology. A thriving breastfed infant with a normal direct level fits breast milk jaundice, which usually clears by 3 months; breastfeeding continues.
Direct bilirubin cutoffs differ (NASPGHAN/ESPGHAN above 1.0 mg/dL, NICE above 25 micromol/L); pale stool overrides both. This post follows AAP 2022 for unconjugated bilirubin and NASPGHAN/ESPGHAN for cholestasis.
Clue in the stem, next best step
| Clue in the stem | What it points to | Next best step |
|---|---|---|
| Yellow face and chest at 16 hours of life | Jaundice before 24 hours, likely hemolysis | TSB or TcB now, not at the routine screen |
| Mother's antibody screen positive or never done | Risk of isoimmune hemolysis | Infant blood type and DAT (cord or peripheral blood) |
| DAT-negative boy whose TSB climbs under intensive phototherapy | Possible G6PD deficiency | G6PD activity; if normal during hemolysis, retest at 3 months or later |
| Breastfed, 11% below birth weight, few wet diapers on day 3 | Suboptimal intake | Lactation support, 8 to 12 feeds a day, consider supplementing; no water or dextrose water |
| TSB 1.5 mg/dL below the exchange threshold | Escalation of care | STAT labs, IV fluids, intensive phototherapy, NICU, TSB every 2 hours |
| Day-4 infant with arching, retrocollis and a high-pitched cry | Intermediate or advanced acute bilirubin encephalopathy | Urgent exchange transfusion |
| Thriving breastfed 3-week-old, yellow stools, normal direct bilirubin | Breast milk jaundice | Reassure, keep breastfeeding, confirm the newborn thyroid screen |
| 4-week-old with pale stools, dark urine, direct bilirubin 2.6 mg/dL | Cholestasis; biliary atresia until proven otherwise | Fasting ultrasound and prompt pediatric hepatology referral |
Where students lose points
- Calling day-1 jaundice physiologic and rechecking in the morning; measure it now.
- Choosing the lower curve for the wrong risk factors. Exclusive breastfeeding, a cephalohematoma or a sibling who needed phototherapy make a high level more likely, but only gestational age and the neurotoxicity risk factors pick the curve.
- Choosing water, dextrose water or "stop breastfeeding." The AAP recommends against water and dextrose water, and feeding continues during phototherapy and in breast milk jaundice.
- Trusting a normal G6PD level during active hemolysis or soon after an exchange. It can be falsely normal; retest at least 3 months later.
- Picking a hepatobiliary scan after days of phenobarbital for suspected biliary atresia. Scintigraphy is not a standalone test, and the premedication delays the Kasai. The gold standard is an intraoperative cholangiogram.
Practice question
A 4-week-old girl is brought to clinic for yellow eyes since age 2 weeks. She was born at 39 weeks and is exclusively breastfed. Over the past week her stools have become pale and putty-colored, and her urine stains the diaper dark yellow. Birth weight was 3.3 kg; today she weighs 3.9 kg. Temperature is 37.0 C, pulse 142/min and respirations 38/min. She has scleral icterus, and the liver edge is palpable 3 cm below the right costal margin. Newborn screening was normal. Total bilirubin is 7.8 mg/dL and direct bilirubin 3.4 mg/dL; ALT is 88 U/L, AST 112 U/L and GGT 410 U/L.
Which of the following is the most appropriate next step in management?
- Reassure the parents that this is breast milk jaundice and recheck at 2 months
- Stop breastfeeding for 48 hours and repeat the bilirubin
- Start home phototherapy
- Fasting abdominal ultrasound and prompt referral to pediatric gastroenterology or hepatology
- Hepatobiliary scintigraphy after 5 days of phenobarbital
Show the answer
Answer: D. A direct bilirubin of 3.4 mg/dL is well above 1.0 mg/dL, so this is cholestasis, and pale stools with dark urine make biliary atresia the first diagnosis to exclude; the high GGT fits. Get a fasting ultrasound and refer promptly: about 70% of infants regain bile flow when the Kasai is done within 60 days of life, and fewer than 25% after 90 days. She is 28 days old.
Why the others are wrong. A: breast milk jaundice is unconjugated with normal stools, and waiting could close the Kasai window. B: stopping breastfeeding does nothing for cholestasis. C: phototherapy acts on unconjugated bilirubin. E: scintigraphy is not a standalone test, and phenobarbital premedication delays the diagnosis.
60-second recall
- Jaundice in the first 24 hours – measure TSB or TcB as soon as possible; think hemolysis.
- When a TcB needs a confirmatory TSB – TcB 15 mg/dL or more, or within 3 mg/dL of the phototherapy threshold.
- AAP 2022 neurotoxicity risk factors – gestational age under 38 weeks, albumin under 3.0 g/dL, hemolysis (isoimmune, G6PD or other), sepsis, recent significant instability.
- When escalation of care starts – TSB within 2 mg/dL of the exchange threshold.
- Abnormal direct bilirubin at any age – above 1.0 mg/dL; with pale stools, start the biliary atresia workup now.
Next: browse every Shelf Prep post, review initial vs best diagnostic tests, present a newborn case with MedRise Viva, or see MedRise for students.
Sources
- Kemper AR, et al. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation (AAP). Pediatrics, 2022
- Fawaz R, et al. Guideline for the evaluation of cholestatic jaundice in infants (NASPGHAN/ESPGHAN). J Pediatr Gastroenterol Nutr, 2017
- NICE. Jaundice in newborn babies under 28 days (CG98), 2010, updated 2023
- Par EJ, et al. Neonatal hyperbilirubinemia: evaluation and treatment. Am Fam Physician, 2023
- Chastain AP, et al. Managing neonatal hyperbilirubinemia: an updated guideline. JAAPA, 2024 (PubMed)
- Gao C, et al. Breast milk constituents and breast milk jaundice: a systematic review. Nutrients, 2023 (PubMed)
MedRise Shelf Prep is educational content for exam preparation only. It is not medical advice and does not replace current guidelines, your school's materials or clinical judgment.


